XML 40 R29.htm IDEA: XBRL DOCUMENT v3.19.2
Acquisitions (Details Narrative) - USD ($)
3 Months Ended
Apr. 23, 2019
Apr. 22, 2019
Mar. 31, 2019
Mar. 31, 2018
Jun. 30, 2019
Apr. 21, 2019
Dec. 31, 2018
Common stock, par value         $ 0.01   $ 0.01
Common stock, shares issued         83,469,967   6,843,802
Common stock, shares outstanding         83,469,967   6,843,802
Shareholders [Member]              
Common stock, shares outstanding           41,419,934  
Equity ownership percentage   15.00%          
Common Stock [Member]              
Conversion of shares     80,772        
Shares issued during the period     20,750 50,000      
Merger Agreement [Member]              
Conversion of shares   10,318,746          
Common stock, shares issued 82,419,967 41,419,934          
Common stock, shares outstanding 82,419,967 41,419,934          
Merger Agreement [Member] | Contingent Value Right [Member]              
Percentage of net proceeds from merger   75.00%          
Net proceeds from merger   $ 500,000          
Merger Agreement [Member] | Oncotelic [Member]              
Conversion of shares   41,000,033          
Common stock, shares outstanding   10,318,746          
Merger Agreement [Member] | Oncotelic [Member] | Former Shareholders [Member]              
Shares to be issued during period preferred stock   10,000          
Merger Agreement [Member] | Oncotelic [Member] | Converted Options [Member]              
Conversion of shares   3,102,411          
Merger Agreement [Member] | Oncotelic [Member] | Converted Warrants [Member]              
Conversion of shares   150,000          
Merger Agreement [Member] | Series A Convertible Preferred Stock [Member]              
Conversion of shares   0.01877292          
Merger Agreement [Member] | Series A Convertible Preferred Stock [Member] | Oncotelic [Member]              
Conversion of shares 193,713 193,713          
Shares issued during the period   77,154          
Stock issued preferred stock conversion basis preferred stock which converted at a 1:1,000 ratio            
Merger Agreement [Member] | Common Stock [Member]              
Common stock, par value   $ 0.01          
Conversion of shares 193,712,995 3.97335267          
Conversion of shares, par value   $ 0.01          
Merger Agreement [Member] | Common Stock [Member] | Oncotelic [Member]              
Conversion of shares   1,000          
Common stock, shares outstanding   7,866,335          
Merger Agreement [Member] | Common Stock [Member] | Oncotelic [Member] | Former Shareholders [Member]              
Shares issued during the period   2,100,000